复发性呼吸道乳头瘤治疗的进展:辅助性内脉贝瓦西祖马布的影响,潜力和从一系列病例研究中的见解
Divya Nayani1, Mounika Kasireddy1, T Shankar1
1Department of Otorhinolaryngology, Government ENT Hospital, Osmania Medical College, Door No.5-1-174, Opposite State Bank of India Head Office, Bank Street Road Koti, Hyderabad, 500095 India.
概括
内溶性贝瓦西祖马布 (阿瓦斯) 治疗显著改善了复发性呼吸道乳头炎的结果. 这种治疗增加了手术之间的时间,并减少了手术频率,为患者提供了安全有效的选择.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 复发性呼吸道乳头炎 (RRP) 是一种罕见的,侵袭性良性疾病,由HPV 6/11引起.
- RRP需要频繁的手术,影响患者的生活质量.
- 目前治疗的局限性突显出需要有效的辅助疗法.
研究的目的:
- 评估内伤性贝瓦齐祖马布作为RRP辅助疗法的疗效和安全性.
- 评估贝瓦西祖马布对外科手术频率和患者结局的影响.
- 从RRP患者的病例序列分析中提供见解,这些患者接受了bevacizumab治疗.
主要方法:
- 对13名RRP患者 (3-30岁) 进行前性研究,每4周接受内溶性贝瓦西祖马布 (2.5毫克/毫升) 治疗.
- 收集的数据包括每年的操作程序,程序之间的时间和Derkay分数.
- 患者有≥4次没有先前辅助治疗的外科手术史;喉是主要受影响的区域.
主要成果:
- 静脉注射贝瓦西祖马布显著增加了手术程序之间的持续时间.
- 每年手术手术的数量在治疗后减少.
- 观察到Derkay得分的整体改善,没有报告的不良药物影响.
结论:
- 内溶性贝瓦西祖马布是一种安全有效的辅助治疗复发性呼吸道乳头瘤.
- 贝瓦西祖马布治疗减少了手术负担,并改善了RRP患者的临床成绩.
- 这种方法为管理RRP提供了一个有希望的治疗策略.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489


